Zecotek Medical Systems Inc.
TSX VENTURE : ZMS

Zecotek Medical Systems Inc.

September 14, 2005 14:32 ET

Zecotek Medical Systems Inc.: Letter of Intent Extended

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Sept. 14, 2005) - ZECOTEK MEDICAL SYSTEMS INC. (TSX VENTURE:ZMS) ("ZMS" or the "COMPANY")

Dr. Faouzi Zerrouk reports that the Letter Of Intent between Synoptics, an affiliate of Northrop Grumman Corporation Space Technology ("Synoptics") and Zecotek Medical Systems Inc. has been further extended to September 30th 2005.

Synoptics advises that the delay in completing the manufacturing agreement with ZMS is due to Synoptics ongoing efforts to fine-tune its manufacturing process to meet customers' pricing structure. Joseph Rutherford, Vice-President and General Manager of Synoptics explains that they are working very closely with the technical and financial team of large potential customers to ensure that the final product is manufactured to the customer's satisfaction. Dr. Zerrouk reports that Synoptics is making significant progress in meeting the customer's requirements.

Synoptics reports that they continue to experience much success in the growth of the LFS crystals at its facility through the technology transfer received from ZMS. As previously stated, the parties are working toward a manufacturing and distribution agreement relating to the establishment of a Joint Research and Development Relationship as well as the execution of an agreement for the manufacture of Zecotek's LFS scintillation material by Synoptics.

Zecotek Medical Systems Inc. is a market driven, Research and Development bio-photonics company with laboratories and base at the University of British Columbia. ZMS focuses on the creation of advanced materials and integrated optoelectronic devices for high resolution medical imaging, optical precision surgery and biopharmaceutical research. ZMS grows by developing and acquiring Intellectual Property and technology know-how through a very thorough selection mechanism which involves industry leaders and constant interaction with major end-users. ZMS commercializes its technologies through strategic alliances with leading OEM manufacturers and distributors.

On Behalf of the Board,

DR. A. F. ZERROUK, Chairman & CEO

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Contact Information

  • Zecotek Medical Systems Inc.
    Grant Macdonald
    (604) 689-4200